Tokyo, Sept. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058982) titled 'Internet survey on the actual state of treatment and treatment needs related to constipation - CONNECT survey' on Sept. 12.
Study Type:
Observational
Primary Sponsor:
Institute - EA Pharma Co., Ltd.
Condition:
Condition - Constipation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Constipation is a digestive disorder with a high prevalence rate, and has been reported to impair quality of life and reduce work productivity. On the other hand, many patients do not seek medical attention, and treatment methods vary widely, resulting in diverse treatment situations. An online survey will be conducted to investigate the actual state of constipation, treatment situations, treatment needs, and concerns.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - People who have constipation and are registered in the Cross Marketing Inc. survey cooperation panel, and who have agreed to participate in this survey.
Key exclusion criteria - Nothing in particular
Target Size - 2300
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 21 Day
Anticipated trial start date - 2025 Year 10 Month 01 Day
Last follow-up date - 2025 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067343
Disclaimer: Curated by HT Syndication.
